GPhA opposes H.R. 5629, biologics bill

Article

Generic Pharmaceutical Association issues statement on H.R. 5629 biologics bill

Generic Pharmaceutical Association President/CEO Kathleen Jaeger issued a statement on the introduction this week of H.R. 5629, the "Pathway to Biosimilars Act." The

Related Videos
fake news misinformation | Image Credit: Bits and Splits - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.